Compare $CVM vs $RNAZ | Chartloom

Compare

$CVM vs $RNAZ

CEL-SCI Corp · Transcode Therapeutics Inc

CVM

CEL-SCI Corp

RNAZ

Transcode Therapeutics Inc

Compare $CVM vs $RNAZ

Comparing CEL-SCI Corp and Transcode Therapeutics Inc

CVMCEL-SCI Corp

RNAZTranscode Therapeutics Inc

CVMCEL-SCI Corp

Market cap

$34M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.3%

52W performance

-80.7%

FCF yield

-49.4%

RNAZTranscode Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.9%

52W performance

-82.4%

FCF yield

-1146.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CVM

RNAZ

Detailed metrics comparison

CVM

CEL-SCI Corp

RNAZ

Transcode Therapeutics Inc

Market Cap

CVM$34M

RNAZ$2M

Enterprise Value

CVM$34M

RNAZ$-6M

Price

CVM$1.94

RNAZ$1.86

P/E Ratio

CVMN/A

RNAZN/A

P/S Ratio

CVM72.73x

RNAZ0.00x

EV/Sales

CVM72.27x

RNAZ0.00x

EV/EBITDA

CVM0.00x

RNAZ0.00x

P/B Ratio

CVM3.71x

RNAZ0.19x

P/FCF Ratio

CVMN/A

RNAZN/A

EV/FCF

CVM-2.01x

RNAZ0.25x

PEG Ratio

CVMN/A

RNAZN/A

Forward P/E (NTM)

CVMN/A

RNAZN/A

Forward P/S (NTM)

CVMN/A

RNAZN/A

Revenue (TTM)

CVM$0

RNAZ$0

Revenue Growth (YoY)

CVMN/A

RNAZN/A

Forward Rev Growth

CVM0.0%

RNAZ0.0%

Gross Margin (TTM)

CVM0.0%

RNAZ0.0%

Operating Margin (TTM)

CVM0.0%

RNAZ0.0%

EBITDA Margin (TTM)

CVM0.0%

RNAZ0.0%

Net Margin (TTM)

CVM0.0%

RNAZ0.0%

FCF Margin (TTM)

CVMN/A

RNAZN/A

Net Income (TTM)

CVM$-23M

RNAZ$-46M

FCF (TTM)

CVM$-17M

RNAZ$-23M

EPS (TTM)

CVM-$1.87

RNAZ-$48.35

ROE (TTM)

CVM-20214.0%

RNAZ-3928.0%

ROA (TTM)

CVM-10078.0%

RNAZ-3601.0%

ROIC (TTM)

CVM-12370.0%

RNAZ-3922.0%

Cash

CVM$7M

RNAZ$8M

Debt

CVM$6M

RNAZ$652K

Net Cash/Debt

CVM$256K

RNAZ$8M

Current Ratio (TTM)

CVM1.48x

RNAZ1.97x

Quick Ratio (TTM)

CVM1.29x

RNAZ1.55x

Debt/Equity (TTM)

CVM0.57x

RNAZ0.00x

Debt/Assets (TTM)

CVM0.0%

RNAZ0.0%

Interest Coverage (TTM)

CVMN/A

RNAZN/A

Net Debt/EBITDA (TTM)

CVM0.00x

RNAZ0.00x

Beta

CVM0.62

RNAZ1.29

52W Performance

CVM-80.7%

RNAZ-82.4%

YTD Performance

CVM-62.3%

RNAZ-74.9%

% from 52W High

CVM-81.3%

RNAZ-91.1%

% from 52W Low

CVM118.0%

RNAZ22.4%

Asset Turnover (TTM)

CVM0.01x

RNAZ0.00x

FCF Yield (TTM)

CVM-49.4%

RNAZ-1146.9%

Earnings Yield (TTM)

CVM-67.0%

RNAZ-2347.6%

Dividend Yield (TTM)

CVMN/A

RNAZN/A

Rule of 40

CVM0.0

RNAZ0.0

EV/GP/RG

CVMN/A

RNAZN/A

Ticker research

View CVM research View RNAZ research

Metric	CVM CEL-SCI Corp	RNAZ Transcode Therapeutics Inc
Market & Valuation
Market Cap	$34M	$2M
Enterprise Value	$34M	$-6M
Price	$1.94	$1.86
P/E Ratio	N/A	N/A
P/S Ratio	72.73x	0.00x
EV/Sales	72.27x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.71x	0.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	0.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-46M
FCF (TTM)	$-17M	$-23M
EPS (TTM)	-$1.87	-$48.35
ROE (TTM)	-20214.0%	-3928.0%
ROA (TTM)	-10078.0%	-3601.0%
ROIC (TTM)	-12370.0%	-3922.0%
Financial Health
Cash	$7M	$8M
Debt	$6M	$652K
Net Cash/Debt	$256K	$8M
Current Ratio (TTM)	1.48x	1.97x
Quick Ratio (TTM)	1.29x	1.55x
Debt/Equity (TTM)	0.57x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.29
52W Performance	-80.7%	-82.4%
YTD Performance	-62.3%	-74.9%
% from 52W High	-81.3%	-91.1%
% from 52W Low	118.0%	22.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-49.4%	-1146.9%
Earnings Yield (TTM)	-67.0%	-2347.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CVM research	View RNAZ research

Valuation

P/S Ratio

RNAZ

0.00x

CVM

72.73x

EV/FCF

CVM

-2.01x

RNAZ

0.25x

Growth & revenue

Forward Revenue Growth

CVM

0.0%

RNAZ

0.0%

Profitability & performance

Gross Margin

CVM

0.0%

RNAZ

0.0%

ROE

RNAZ

-3928.0%

CVM

-20214.0%

FCF Yield %

CVM

-49.4%

RNAZ

-1146.9%

52-Week Performance

CVM

-80.7%

RNAZ

-82.4%

Detailed metrics comparison

CVM

CEL-SCI Corp

RNAZ

Transcode Therapeutics Inc

Market Cap

CVM$34M

RNAZ$2M

Enterprise Value

CVM$34M

RNAZ$-6M

Price

CVM$1.94

RNAZ$1.86

P/E Ratio

CVMN/A

RNAZN/A

P/S Ratio

CVM72.73x

RNAZ0.00x

EV/Sales

CVM72.27x

RNAZ0.00x

EV/EBITDA

CVM0.00x

RNAZ0.00x

P/B Ratio

CVM3.71x

RNAZ0.19x

P/FCF Ratio

CVMN/A

RNAZN/A

EV/FCF

CVM-2.01x

RNAZ0.25x

PEG Ratio

CVMN/A

RNAZN/A

Forward P/E (NTM)

CVMN/A

RNAZN/A

Forward P/S (NTM)

CVMN/A

RNAZN/A

Revenue (TTM)

CVM$0

RNAZ$0

Revenue Growth (YoY)

CVMN/A

RNAZN/A

Forward Rev Growth

CVM0.0%

RNAZ0.0%

Gross Margin (TTM)

CVM0.0%

RNAZ0.0%

Operating Margin (TTM)

CVM0.0%

RNAZ0.0%

EBITDA Margin (TTM)

CVM0.0%

RNAZ0.0%

Net Margin (TTM)

CVM0.0%

RNAZ0.0%

FCF Margin (TTM)

CVMN/A

RNAZN/A

Net Income (TTM)

CVM$-23M

RNAZ$-46M

FCF (TTM)

CVM$-17M

RNAZ$-23M

EPS (TTM)

CVM-$1.87

RNAZ-$48.35

ROE (TTM)

CVM-20214.0%

RNAZ-3928.0%

ROA (TTM)

CVM-10078.0%

RNAZ-3601.0%

ROIC (TTM)

CVM-12370.0%

RNAZ-3922.0%

Cash

CVM$7M

RNAZ$8M

Debt

CVM$6M

RNAZ$652K

Net Cash/Debt

CVM$256K

RNAZ$8M

Current Ratio (TTM)

CVM1.48x

RNAZ1.97x

Quick Ratio (TTM)

CVM1.29x

RNAZ1.55x

Debt/Equity (TTM)

CVM0.57x

RNAZ0.00x

Debt/Assets (TTM)

CVM0.0%

RNAZ0.0%

Interest Coverage (TTM)

CVMN/A

RNAZN/A

Net Debt/EBITDA (TTM)

CVM0.00x

RNAZ0.00x

Beta

CVM0.62

RNAZ1.29

52W Performance

CVM-80.7%

RNAZ-82.4%

YTD Performance

CVM-62.3%

RNAZ-74.9%

% from 52W High

CVM-81.3%

RNAZ-91.1%

% from 52W Low

CVM118.0%

RNAZ22.4%

Asset Turnover (TTM)

CVM0.01x

RNAZ0.00x

FCF Yield (TTM)

CVM-49.4%

RNAZ-1146.9%

Earnings Yield (TTM)

CVM-67.0%

RNAZ-2347.6%

Dividend Yield (TTM)

CVMN/A

RNAZN/A

Rule of 40

CVM0.0

RNAZ0.0

EV/GP/RG

CVMN/A

RNAZN/A

Ticker research

View CVM research View RNAZ research

Metric	CVM CEL-SCI Corp	RNAZ Transcode Therapeutics Inc
Market & Valuation
Market Cap	$34M	$2M
Enterprise Value	$34M	$-6M
Price	$1.94	$1.86
P/E Ratio	N/A	N/A
P/S Ratio	72.73x	0.00x
EV/Sales	72.27x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.71x	0.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	0.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-46M
FCF (TTM)	$-17M	$-23M
EPS (TTM)	-$1.87	-$48.35
ROE (TTM)	-20214.0%	-3928.0%
ROA (TTM)	-10078.0%	-3601.0%
ROIC (TTM)	-12370.0%	-3922.0%
Financial Health
Cash	$7M	$8M
Debt	$6M	$652K
Net Cash/Debt	$256K	$8M
Current Ratio (TTM)	1.48x	1.97x
Quick Ratio (TTM)	1.29x	1.55x
Debt/Equity (TTM)	0.57x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.29
52W Performance	-80.7%	-82.4%
YTD Performance	-62.3%	-74.9%
% from 52W High	-81.3%	-91.1%
% from 52W Low	118.0%	22.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-49.4%	-1146.9%
Earnings Yield (TTM)	-67.0%	-2347.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CVM research	View RNAZ research